Insiders Aren’t Buying Pfizer Stock, and That Could Help
Pfizer stock hovers around the $26 level as insiders aren’t buying Pfizer stock. Analysts point to a patient, value-f...
Choosing between price and cap weighting depends on your objectives and risk tolerance. This guide highlights strengths and trade-offs.
26,659 articlesPfizer stock hovers around the $26 level as insiders aren’t buying Pfizer stock. Analysts point to a patient, value-f...
Berkshire Hathaway disclosed a $2.65 billion stake in Delta Air Lines, marking a sharp shift from Buffett-era airline...
Bitcoin extended its decline into a fifth straight month, posting double-digit losses in February as macro headwinds ...
A worrying trend shows high school students taking on large loans to pursue trades that pay modest starting wages. Th...
UBS contends that the math behind DeSantis' flagship property tax relief may not deliver the promised relief. Florida...
A legendary macro investor who warned about the 2008 bubble has sold Alphabet and moved into AI hardware names, signa...
A US traveler finds herself stranded in Dubai as regional tensions flare after attacks tied to Iran. The story highli...
Institutional appetite for bitcoin ETFs intensified, with roughly $1.15 billion flowing in over the latest week and a...
Fifteen years after Hal Finney warned that rebooting Bitcoin would erode credibility, markets still weigh the lesson ...
NVIDIA trades around the $200 level as AI-chip sentiment wobbles. The next move—breakout or breakdown— hinges on upco...
Boeing’s stock is drawing fresh attention as defense-focused equities outperform, underpinned by a robust backlog and...
As Trump visits Beijing, investors weigh whether U.S. tech giants can gain durable access in China. History suggests ...